MS vs. WBA

Last updated Jun 4, 2026

MS (Morgan Stanley) and WBA (Walgreens Boots Alliance, Inc.) are both stocks. MS operates in Capital Markets (Financial Services), while WBA operates in Pharmaceutical Retailers (Healthcare). At a 0.32 correlation, their price movements are largely independent.

Performance

MS vs. WBA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Morgan Stanley (MS) and Walgreens Boots Alliance, Inc. (WBA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

MS

• 1D: -2.25%
• 1M: 11.77%
• YTD: 19.66%
• 6M: 22.29%
• 1Y: 67.25%
• 3Y*: 39.95%
• 5Y*: 21.31%
• 10Y*: 26.51%

WBA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

MS vs. WBA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MS Morgan Stanley	19.66%	45.16%	39.73%	13.93%	-10.34%	46.65%	38.09%	32.67%	-22.76%	26.61%
WBA Walgreens Boots Alliance, Inc.	0.00%	28.40%	-61.34%	-25.09%	-25.06%	35.78%	-29.38%	-10.99%	-3.65%	-10.51%

Correlation

The correlation between MS and WBA is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.04
Correlation (3Y) Calculated over the trailing 3-year period	0.21
Correlation (5Y) Calculated over the trailing 5-year period	0.32
Correlation (10Y) Calculated over the trailing 10-year period	0.36
Correlation (All Time) Calculated using the full available price history since Feb 24, 1993	0.32

The correlation between MS and WBA shifts across timeframes, from -0.04 (1 year) to 0.36 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Total Revenue (TTM) MS : $120.22B WBA : $154.58B
Gross Profit (TTM) MS : $69.72B WBA : $26.47B
EBITDA (TTM) MS : $27.21B WBA : -$2.92B

Return for Risk

MS vs. WBA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MS

MS Risk / Return Rank: 89
MS Sharpe Ratio Rank: 93
MS Sortino Ratio Rank: 90
MS Omega Ratio Rank: 90
MS Calmar Ratio Rank: 85
MS Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MS vs. WBA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Morgan Stanley (MS) and Walgreens Boots Alliance, Inc. (WBA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MS	WBA	Difference
Sharpe ratio: Return per unit of total volatility	2.68	—	—
Sortino ratio: Return per unit of downside risk	3.29	—	—
Omega ratio: Gain probability vs. loss probability	1.45	—	—
Calmar ratio: Return relative to maximum drawdown	3.59	—	—
Martin ratio: Return relative to average drawdown	11.89	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	MS	WBA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.68	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.75	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.85	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.29	—	—

Drawdowns

Drawdown Indicators

	MS	WBA	Difference
Max Drawdown Largest peak-to-trough decline	-88.12%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-18.83%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-29.24%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-32.38%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-51.33%	—	—
Current Drawdown Current decline from peak	-2.25%	—	—
Average Drawdown Average peak-to-trough decline	-33.72%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	5.67%	—	—

Volatility

Volatility by Period

	MS	WBA	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.98%	—	—
Volatility (6M) Calculated over the trailing 6-month period	20.82%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	25.19%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	28.65%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	31.48%	—	—

Dividends

MS vs. WBA - Dividend Comparison

MS's dividend yield for the trailing twelve months is around 1.90%, while WBA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MS Morgan Stanley	1.90%	2.17%	2.82%	3.49%	3.47%	2.14%	2.04%	2.54%	2.77%	1.72%	1.66%	1.73%
WBA Walgreens Boots Alliance, Inc.	0.00%	0.00%	10.72%	7.35%	5.13%	3.62%	4.64%	3.04%	2.46%	2.13%	1.78%	1.64%

Financials

Frequently Asked Questions

Can I hold both MS and WBA in my portfolio?

MS and WBA have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.